GLP-3 Receptor Agonist Analog (RTA designation – Retatrutide analog) is supplied as lyophilized powder in 10mg vials, providing expanded capacity for triple incretin receptor agonist research and comprehensive multi-target metabolic investigation. This formulation enables detailed mechanistic evaluation of GLP-1/GIP/GCG triple receptor agonism.

Chemical Composition:

• Chemical Name: Triple Incretin Receptor Agonist Analog (GLP-1/GIP/GCG)
• Molecular Formula: C206H324N56O61S8 (representative structure)
• Molecular Weight: ~4,727 g/mol (approximate)
• Compound Class: Tripeptide receptor agonist; incretin-glucagon dual target compound

The 10mg vial enables comprehensive characterization of triple-agonist signaling cascades, investigation of tissue-specific receptor expression patterns for GLP-1, GIP, and glucagon receptors, assessment of differential signaling outcomes in pancreatic versus extrapancreatic tissues, and evaluation of metabolic superiority of triple-agonism relative to dual or single-receptor approaches. Research encompasses mechanistic studies of GLP-1/GIP/GCG signaling integration and pathway cross-talk, investigation of weight loss and appetite suppression mechanisms combining incretin and glucagon signaling, assessment of cardiovascular effects from combined receptor activation, and characterization of potential adverse effects from simultaneous multi-receptor engagement in preclinical safety evaluation.

Research Applications:

• GLP-1/GIP/GCG receptor signaling cascade characterization and pathway integration analysis
• Tissue-specific triple receptor expression mapping and functional contribution assessment
• Weight loss, food intake suppression, and energy expenditure evaluation in obese models
• Cardiovascular function assessment (blood pressure, heart rate, cardiac function)
• Comparative safety profiling relative to single and dual incretin receptor agonists

Storage and Handling:

• Store at -20°C in sealed vials protected from light exposure
• Maintain desiccated conditions to preserve peptide stability
• Reconstitute fresh with sterile water for each experimental batch
• Reconstituted solutions remain stable at 4°C for 7 days maximum

Product Specifications:

• Form: Lyophilized powder
• Quantity: 10mg per vial
• Purity: >95% by HPLC
• Appearance: White crystalline lyophilized powder

FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.